Acute myocardial infarction management

The effect of Streptokinase on ST segment Resolution among diabetic patients with acute myocardial infarction

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015052722445N1

Enrollment

342

Registered

2015-07-18

Start date

2013-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction.

Interventions

1.5 million units of IV Streptokinase diluted in 100 ml of Saline.

Treatment - Drugs

1.5 million units of IV Streptokinase diluted in 100 ml of Saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute chest pain or other symptoms of AMI who referred to Firoozabadi Hospital during the first 6 hours of onset included in this study. Patients who have MI in their past medical history or those with LBBB in addition to patients who received SK for any reason excluded from this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
ST resolution. Timepoint: Three hours after SK injection. Method of measurement: ECG.	—

Secondary

Measure	Time frame
Pain reduction. Timepoint: Three hours after SK injection. Method of measurement: Numerical Rating Scale (NRS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyedeh Mahboobeh Rezanezhad

Shahid Beheshti Medical University

rezanezhad.mahboobeh@gmail.com+98 21 8895 6612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026